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Considering the importance of diet in prevention of oxidative stress-related diseases including hypertension, this study was
undertaken to evaluate the in vitro antioxidant and ACE inhibitory activities of selected culinary-medicinal mushrooms extracted
by boiling in water for 30min. Antioxidant capacity was measured using the following assays: DPPH free radical scavenging
activity, β-carotene bleaching, inhibition of lipid peroxidation, reducing power ability, and cupric ion reducing antioxidant
capacity (CUPRAC). Antioxidant potential of each mushroom species was calculated based on the average percentages relative
to quercetin and summarized as Antioxidant Index (AI). Ganoderma lucidum (30.1%), Schizophyllum commune (27.6%), and
Hericiumerinaceus (17.7%)showedrelatively highAI.Totalphenolicsinthesemushroomsvariedbetween 6.19to63.51mgGAE/g
extract. In theACE inhibitoryassay,G. lucidum wasshownto be themostpotent species (IC50 = 50μg/mL).Basedonourﬁndings,
culinary-medicinal mushrooms can be considered as potential source of dietary antioxidant and ACE inhibitory agents.
1.Introduction
Reactive oxygen species (ROS) have been implicated in food
deterioration as well as pathogenesis of various human
diseases and aging-related disorders [1]. Epidemiological
studies have revealed the close association between intake
of food rich in antioxidants such as vegetables, fruits, and
cereals with prevention of the aforementioned pathologies
[2]. Intake of exogenous antioxidants is crucial to maintain
an adequate level of antioxidants in order to balance the
ROS especially when human in vivo antioxidant defence and
repair systems are considered to be insuﬃcient to totally
prevent the damage. Oxidative stress has been linked to
hypertension—imbalance in superoxide and nitric oxide
production will lead to reduced vasodilation [3]. If hyper-
tension persists for a long period, it could be one of the risk
factors for strokes, heart diseases, and eventually leading to
chronic renal failure.
Synthetic antioxidants that are widely used in the
food industry such as butylated hydroxyanisole (BHA),
butylatedhydroxytoluene(BHT),and tert-butylated hydrox-
yquinine (TBHQ) have been reported to be carcinogenic;
thus, their use has been restricted [4]. Treatments by
administration of antihypertensive drugs, for example,
inhibitors of the angiotensin I-converting enzyme (ACE)
aim to reduce blood pressure and lower the risk of hyper-
tension complications. However, the use of synthetic ACE
inhibitors such as captopril and enalapril caused serious
side eﬀects including dry cough, skin rashes, and allergic
reactions [5]. This situation has prompted the search for
potential antioxidant and ACE inhibitors from natural
sources.
Combination of both biological activities in one mul-
tifunctional preparation, especially in food, was suggested
to be useful for controlling the risk of cardiovascular
diseases [6]. In fact, M¨ unzel and Keaney [3]p r o p o s e d
that ACE inhibitors possess novel antioxidant strategy by
improving vasoconstriction, increasing bioactivity of nitric
oxide, and inhibiting vascular superoxide production at its
source. Therefore, consumption of antioxidant-rich foods
which possess ACE inhibitory activity can be considered
as an alternative therapy for treatment of hypertension
especially for prehypertensive patients whose blood pressure
is marginally or mildly high but not high enough to warrant
the prescription of blood-pressure-lowering medications as
suggested by Chen et al. [7].2 Evidence-Based Complementary and Alternative Medicine
Mushrooms are considered as functional food with
physiological beneﬁcial constituents [1] and consumption
of several mushrooms such as Agaricus bisporus, Lentinula
edodes, and Pleurotus spp. has become popular over the
years. The broad medicinal values of mushrooms have a
promising future as a branch of alternative medicine [8]a n d
hence, scientiﬁc research directed to validation of claimed
medicinal properties is vital. Mushroom decoctions in folk
medicine often involve the use of hot water to extract soluble
components from the fruiting body. Accordingly, crushed or
small pieces of the fruiting body are boiled and the resulting
decoction is consumed. Besides that, mushrooms are usually
not eaten raw but subjected to various food processing
procedures so that they will be more readily assimulated by
digestion [9]. Hence, it can be said that preparation of hot
water extracts similate cooking conditions—the typical way
of how edible mushrooms are consumed.
Information obtained from analysis using hot water
extracts was considered a better indicator of biological
activities especially upon consumption [10, 11]. Since most
reports on biological properties of mushrooms utilised
various organic solvents for preparation of extracts, it is
rather diﬃcult to make comparisons between diﬀerent
laboratories taking into account variation in the procedures.
Evaluation of several mushroom species using the same set
of procedures is vital for accurate and fair comparison of
biologicalactivitiesstudied.Hence,theobjectiveofthisstudy
is to analyse the in vitro antioxidant and ACE inhibitory
activities of hot water extracts of selected culinary-medicinal
mushrooms.
2.Materialsand Methods
2.1. Mushroom Collection. Fourteen species of culinary-
medicinal mushrooms used in this study (Table 1)w e r e
obtained from mushroom farms and supermarkets in Selan-
gor, Malaysia. The samples were identiﬁed and authenticated
by experts in the Mushroom Research Centre, University of
Malaya; voucher specimens were deposited in the University
of Malaya herbarium (KLU).
2.2. Preparation of Mushroom Hot Water Extracts. All mush-
room fruiting bodies were cleaned, cut into smaller pieces,
and boiled in distilled water at the ratio of 1:10 (w/v)
at 100◦C for 30min. Boiled mushrooms were cooled to
room temperature, removed by using Whatman No. 1 ﬁlter
paper and hot water extracts obtained were freeze-dried
(Labconco). The extracts were kept in desiccator at room
temperature for further analysis.
2.3. Estimation of Total Phenolic Content. Total phenolic
contentofthemushroom extractswasestimatedusing Folin-
Ciocalteu reagent according to the method of Slinkard and
Singleton [12] with some modiﬁcations. Initially, 250μLo f
eachmushroomextractwasmixedwith250μLof10%Folin-
Ciocalteu reagent, followed with the addition of 500μLo f
saturated sodium carbonate (10% aqueous solution) after
2min of incubation at room temperature. The mixture was
kept in the dark for 1h before absorbance was taken at
750nm. A calibration curve using gallic acid (2–10μg/mL)
was prepared. Total phenolic content of the mushroom
extracts was expressed as gallic acid equivalents (GAEs),
which reﬂect the phenolic content as the amount of gallic
acid (mg) in 1g of extract.
2.4. Antioxidant Capacity Assays. In all assays, quercetin,
butylated hydroxyanisole (BHA), and ascorbic acid were
used as positive control.
2.5. Scavenging Eﬀect on 1,1-Diphenyl-2-Picrylhydrazyl
(DPPH) Radicals. The DPPH free radical scavenging
activity of the extracts was measured according to the
method of Brand-Williams et al. [13]. Stock solution
of each mushroom extract (50mg/mL) was diluted to a
c o n c e n t r a t i o ni nt h er a n g eo f0 . 1t o5 0 m g / m L .F o rt h e
test, 3.9mL of 0.06mM DPPH radical (Sigma) was added
to 0.1mL of mushroom extract. Reaction mixture was
vortexed and absorbance was measured at 515nm using a
spectrophotometer with methanol as theblank. The decrease
in absorbance was monitored at 0min, 1min, 2min, and
every 15min until the reaction has reached a plateau. The
time taken to reach the steady state was determined by
one-way analysis of variance (ANOVA). The DPPH free
radical scavenging activity, expressed as percentage of radical
scavenging activity, was calculated as follows:
Radical scavenging activity (SA) =
A0 − As
A0
× 100, (1)
where A0 is the absorbance of 0.06mM methanolic DPPH
only whereas As is the absorbance of the reaction mixture.
2.6. β-Carotene Bleaching Activity. β-carotene bleaching
activity of the mushroom extracts was evaluated using β-
carotene-linoleic acid model system previously described
[14] with some modiﬁcations. Brieﬂy, 2mg of β-carotene
in 10mL chloroform was mixed with 40μLo fl i n o l e i ca c i d
and 400μL of Tween 80 emulsiﬁer. Chloroform was allowed
to evaporate under vacuum, prior to addition of 100mL
of distilled water with vigorous shaking. Then, 4.8mL of
the mixture was transferred into tubes containing diﬀerent
concentrations of extract. Upon addition of the emulsion
into each tube, the zero time absorbance was measured at
470nmusingaspectrophotometer.Theemulsionsystemwas
incubated for 2h at 50◦C.
2.7. Inhibition of Lipid Peroxidation of Buﬀered Egg Yolk. The
ability of mushroom extracts to inhibit lipid peroxidation
was determined according to the method of Daker et al.
[15]. The reaction mixture contained 1mL of fowl egg yolk
emulsiﬁed with 0.1M phosphate buﬀer (pH 7.4) to obtain
a ﬁnal concentration of 25g/L and 100μL of 1000μMF e 2+.
The stock solution of each mushroom extract (360mg/mL)
was prepared and then dilutedto ﬁnal extract concentrations
of 0.1–30mg/mL. The mixture was incubated at 37◦Cf o r
1h before being treated with 0.5mL of freshly prepared 15%
trichloroacetic acid (TCA) and 1.0mL of 1% thiobarbituricEvidence-Based Complementary and Alternative Medicine 3
Table 1: Total phenolic content of culinary-medicinal mushrooms studied.
Mushroom species Total phenolic content
Scientiﬁc name Commonname(s) (mg GAE/g extract)
Agrocybe sp. Black poplar mushroom;yangimatusutake (Japanese) 25.40 ± 1.52
g
Auricularia auricular-judae Jelly mushroom; Judas’s ear fungus; kikurage “tree-jelly ﬁsh” (Japanese);
m` uˇ er “wood ear” (Chinese) 6.19 ±0.87
a
Flammulina velutipes Golden needle mushroom; enokitake (Japanese); jιnzheng¯ u (Chinese) 16.69 ±2.62
d,e
Ganoderma lucidum Reishi (Japanese);lιngzh¯ ı(Chinese) 63.51± 3.11
h
Hericium erinaceus Lion’s mane mushroom;yamabushitake “mountain-hidden mushroom”
(Japanese);h´ out´ oug¯ u “monkey head mushroom” (Chinese) 10.20 ±2.25
a,b
Lentinula edodes Forest mushroom,shiitake “shii mushrooms”(Japanese);xi¯ angg¯ u
“fragrant mushroom” (Chinese) 14.70 ±3.01
c,d
Pleurotus cystidiosus Abalone oyster; summer oyster mushroom 9.26 ±0.77
a,b
Pleurotus eryngii King oyster; king trumpet mushroom; French horn mushroom; eringi
(Japanese);x` ıngb` aog¯ u “almond abalone mushroom” (Chinese) 20.95 ± 2.39f
Pleurotus ﬂabellatus Pink oyster mushroom 20.24 ±0.68e,f
Pleurotus ﬂorida White oyster mushroom 12.24 ±1.17
b,c
Pleurotus sajor-caju Grey oyster mushroom 17.70 ±2.12d,e,f
Schizophyllum commune Bracket fungus; spilt-gill fungus; liezhejun (Chinese) 16.47 ±0.42
d,e
Termitomyces heimii “Termite nest fungus” 11.31 ±0.42
b,c
Volvariella volvaceae Paddy straw mushroom;fukurotake (Japanese);cˇ aog¯ u (Chinese) 20.88 ± 3.13
f
Positive controls
Quercetin 194.24 ±7.58i
Butylated hydroxyanisole (BHA) 931.86 ±49.78k
Ascorbic acid∗ 25.40 ± 1.39
g
Values were expressed as mean ± standard deviation of three replicate determinations.
Mean values in a column with diﬀerent lowercase letters (a–k) indicate signiﬁcant diﬀerence at P<. 05.
∗The value is an estimation of total reducing capacity of ascorbic acid instead of its phenolic content.
acid (TBA). The reaction tubes were further incubated
in boiling water bath for 10min. Once cooled to room
temperature, the tubes were centrifuged at 3500 × gf o r
10min to remove precipitated protein. Finally, 100μLo f
supernatant was subjected to an absorbance reading at
532nm to measure the formation of thiobarbituric acid
reactive substances (TBARS). Buﬀered egg with Fe2+ only
was used as control in this assay. The percentage inhibition
was calculated from the following equation:
Inhibition (%) =
A0 − As
A0
× 100, (2)
where A0 is the absorbance of the control whereas As is the
absorbance of the sample.
2.8. Reducing Power Ability. Reducing power of the mush-
room extracts was determined according to the method
of ¨ Ozt¨ urk et al. [16]. Diluted mushroom extracts were
mixed with 2.5mL of 0.2M phosphate buﬀer (pH 6.6) and
2.5mL of 1% potassium ferricyanide. Reaction mixtures
were incubated at 50◦C for 20min. After the addition of
2.5mL of10% TCA,the mixture were centrifuged for10min
at 1000 rpm. Then, 2.5mL of the supernatant were mixed
with 2.5mL of distilled water and 0.5mL of 0.1% ferric
chloride. Absorbance was measured at 700nm against a
blank.
2.9. Cupric-Ion-Reducing Antioxidant Capacity (CUPRAC).
CUPRAC assay was performed according to the method
by ¨ Ozt¨ urk et al. [16] with some modiﬁcations. The test
mixture contained 1mL of 10mM of copper (II), 7.5mM
neocuproine, and 1M ammonium acetate buﬀer (pH 7.0).
Brieﬂy, 1mL of diluted mushroom extracts in the concentra-
tionrange of0.1–20mg/mL were added tothe reaction tubes
to achieve ﬁnal volume of 4mL. The tubes were incubated
for30min atroomtemperaturebeforeabsorbanceat450nm
was recorded against a blank.
2.10. Antioxidant Index (AI). The Antioxidant Index as
proposed by Puttaraju et al. [17] was used to grade the
selected culinary-medicinal mushrooms on the basis of their
antioxidant potential. Mushroom extracts were graded in
a numerical scale based on quercetin which is considered
to be equivalent to 100 (Table 5). AI represents the average
relative percentages compared to quercetin obtained using
ﬁve diﬀerent methodologies for evaluation of antioxidant
capacity described above.
2.11.ACEInhibitory Assay. TheACEinhibitoryactivityassay
was performed according to the method by Nakamura et
al. [18] with some modiﬁcations. Brieﬂy, 200μLo f5 m M
hippuryl-L-histidine-L-leucine (HHL) (Sigma) solution was
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was preincubated at 37◦C for 3min. The reaction was
initiated by the addition of 20μL of 0.1U/mL ACE (Sigma)
solution and the mixture was again incubated at 37◦Cf o r
30min. The reaction was terminated with the addition of
250μL of 1N HCl. Then, 1.5mL of ethyl acetate was added
to extract the hippuric acid liberated by the reaction. The
solution was centrifuged for 10min; the ethyl acetate layer
was then aspirated and evaporated under vacuum condition.
The dried hippuric acid was redissolved in 1mL of distilled
water and measured spectrophotometrically at 228nm. The
ACE inhibitory activity of the mushroom extracts was
determined by the following equation:
Percentage of inhibition (%) =
B − A
B −C
× 100, (3)
where A is the absorbance of ACE and mushroom extracts, B
is the absorbance of ACE and HHL and C is the absorbance
of HHL only.
2.12. Statistical Analysis. All analysis was performed in
triplicates and data was recorded as means ± standard
deviation. Analysis was carried out using one-way analysis
of variance (ANOVA) in Statgraphics Plus for Windows
3.0. The test stated any signiﬁcant diﬀerences between the
means at 95% (P<. 05) level were considered as statistically
signiﬁcant. Correlation and regression analysis were carried
out using the Microsoft EXCEL.
3.Resultsand Discussion
3.1. Estimation of Total Phenolic Content. Considering the
physiological importance of phenolic compounds and their
contribution towards total antioxidant capacity, Folin-
Ciocalteu method was used to estimate the total phenolic
content of mushroom extracts. It must be noted that this
reagent does not react exclusively with phenolics, but other
reducing agents, for example, ascorbic acid as well [19,
20]. Hence, results of this test therefore reﬂect the total
reducing capacity of the mushroom extracts and positive
controls tested. Despite its tendency to overestimate the
level of phenolics, this method is still widely employed
prior to quantitative measurement of phenolics using high-
performance liquidchromatography (HPLC)[21].Asshown
in Table 1, total phenolic content of mushroom extracts
tested varied from 6.19 to 63.51mg GAE/g extract with
G. lucidum having the highest phenolic content (63.51 ±
1.11mg GAE/g extract).
Phenolic acids were reported to be the main phenolic
compounds in mushrooms [21]. According to Puttaraju
et al. [17], gallic acid, tannic acid, protocatechuic acid, and
gentisic acids were some of the major phenolics detected
in water extracts of several indigenous edible mushrooms
from India. Besides, several authors have reported the
correlation between the polarity of extraction solvent and
phenolic content of resulting extracts [17, 22]. For instance,
the phenolic content of H. erinaceus hot water extract in
this study was determined to be 10.20 ± 2.25mg GAE/g
extract, which was higher than that of methanolic extracts of
fresh (0.26mg GAE/g extract), oven-dried (2.37mg GAE/g
extract), and freeze-dried fruiting bodies (0.78mg GAE/g
extract) of the same species [23].
3.2. Antioxidant Capacity of Mushrooms. There is no single,
universal method capable of providing an accurate, com-
prehensive picture of antioxidant proﬁle because several
mechanisms underlying antioxidant activity have been pro-
posed including termination of free radical mediated chain
reaction, hydrogen donation, chelation of catalytic ions, and
elimination of peroxides [24]. Thus, a single assay is not
suﬃcient to measure the total antioxidant capacity of the
mushrooms. Moon and Shibamoto [25] recommended that
a combination of electron scavenging and lipid peroxidation
assays be used. The use of simpliﬁed model systems that
closely resemble the main features of a given food system
was suggested by Kuliˇ si´ ce ta l .[ 26]. Multiple assays based
ondiﬀerentantioxidant mechanisms are crucialin providing
am o r er e l i a b l ea p p r o a c ht oa s s e ss the antioxidant capacity
of the mushrooms. In the present study, a total of ﬁve
methods—DPPH free radical scavenging activity, β-carotene
bleaching, inhibition of lipid peroxidation, reducing power
ability, and CUPRAC—were used.
3.3. Scavenging Eﬀect on DPPH Free Radicals. One of the
most common methods for determination of antioxidant
capacity is the DPPH free radical scavenging activity assay
which relies on the reduction of methanolic DPPH solution
in the presence of a hydrogen donating compound (antiox-
idant). The resulting decolourisation upon absorption of
hydrogen from the antioxidant is stoichiometric with respect
to the degree of reduction and the remaining DPPH,
measured after a certain time, corresponds inversely to the
radical scavenging activity of the antioxidant [27].
As shown in Table 2, the scavenging activity of mush-
room extracts towards DPPH free radicals was expressed in
terms of IC50.S i n c eal o w e rI C 50 value indicates stronger
ability of the extracts to act as DPPH radical scavengers,
then it is obvious that the positive controls were excellent
DPPH radical scavengerswith quercetinexhibited >100-fold
higherscavengingactivity (IC50 = 0.03mg/mL) comparedto
the mushroom extracts (IC50 = 5.28–39.05mg/mL). Inves-
tigated mushrooms showed DPPH free radical scavenging
activity, acting possibly as primary antioxidants as suggested
by Tsai et al. [11]. G. lucidum exhibited signiﬁcant radical
scavenging activity with IC50 of 5.28mg/mL, followed
by Agrocybe sp. and P. eryngii having IC50 of 9.56 and
15.42mg/mL respectively. Apparently, F. velutipes displayed
the weakest scavengingactivity with an IC50 of39.05mg/mL.
The ability of hot water extract of other mushrooms to
quench free radicals has been reported earlier. Hot water
extracts of mature and baby Ling chih (Ganoderma tsugae
Murrill)showedexcellentantioxidantactivitieswithlowIC50
of 0.30 and 0.40mg/mL, respectively [10]. In their study,
Chirinang and Intarapichet [28] noticed that the radical
scavenging activity of water extract of Pleurotus ostreatus
(IC50 = 11.56mg/mL) was better than that of P. sajor-
caju (IC50 = 13.38mg/mL) probably due to higher content
of phenolic compounds and dietary ﬁbres. Agaricus blazei,Evidence-Based Complementary and Alternative Medicine 5
Table 2: Antioxidant capacities of selected culinary-medicinal mushrooms as determined by the DPPH free radical scavenging activity,
inhibition of lipid peroxidation using buﬀered egg yolk and β-carotene bleaching assays.
DPPH free radical
scavengingactivity
β-carotene
bleaching assay Lipid peroxidation
Mushroom species IC50 (mg/mL) IC50 (mg/mL) Percentage of inhibition at 10 mg/mL
Agrocybe sp. 9.559 ±0.462a,b,c 12.95 ±0.842e 33.33 ±18.14a
Auricularia auricular-judae 23.916 ±0.106
d,e,f 27.82 ± 0.498
g 56.41 ±2.74
c,d
Flammulina velutipes 39.050 ±5.717h 38.80 ± 0.039h 41.71 ±4.23a,b,c
Ganoderma lucidum 5.280 ± 0.263
a,b 7.94 ±0.783
b,c 57.18 ±14.05
d
Hericium erinaceus 25.471 ±0.039c,d,e 8.76 ±1.567b 47.52± 4.87a,b,c,d
Lentinula edodes 19.093 ±0.296
c,d,e 8.33 ±0.020
b,c,d 38.29 ± 4.16
a,b
Pleurotus cystidiosus 31.500 ±0.053f,g,h 26.08 ± 2.383g 49.83 ±4.3b,c,d
Pleurotus eryngii 15.422 ±0.037
b,c,d 24.71 ± 0.542
g 47.86± 9.22
a,b,c,d
Pleurotus ﬂabellatus 17.857 ±0.000c,d,e 11.97 ±0.317d,e 50.09 ± 6.07b,c,d
Pleurotus ﬂorida 21.233 ±0.045
d,e,f 25.08 ± 0.333
g 56.58 ±7.43
c,d
Pleurotus sajor-caju 23.100 ±0.156d,e,f 17.50 ± 0.012f 42.99± 3.34a,b,c,d
Schizophyllum commune 35.659 ±0.055
g,h 2.21 ±0.237
a 36.24 ± 9.41
a,b
Termitomyces heimii 26.839 ±0.189e,f,g 12.79 ±0.381e 46.32± 2.73a,b,c,d
Volvariella volvaceae 17.832 ±0.020
c,d,e 17.92 ± 0.197
f 50.00 ± 1.47
b,c,d
Positive controls
Quercetin 0.032 ±0.007
a 1.86 ±0.014
a 87.35 ±6.11
e
Butylated hydroxyanisole (BHA) 0.097 ±0.012c 2.76 ±0.014a 75.13 ±2.02e
Ascorbic acid 0.078 ±0.005
b 11.50 ±0.135
c,d,e 81.54 ±1.09
e
Values were expressed as mean ± standard deviation of three replicate determinations.
Mean values in a column with diﬀerent lowercase letters (a–h) indicate signiﬁcant diﬀerence at P<. 05.
Agrocybe cylindracea, and Boletus edulis displayed moderate
DPPH scavenging activities with IC50 of 13.75, 26.98, and
15.78mg/mL, respectively [11]. It has been reported that
the IC50 of hot water extract of Hypsizygus marmoreus was
4.19mg/mL[29]whereasthewhitemutantstrainofthesame
species was less eﬀective with an IC50 of 18.85mg/mL [30].
3.4. β-Carotene Bleaching Activity. For evaluation of antiox-
idant capacity of compounds in emulsions, the β-carotene
bleaching assay is recommended. Food systems usually
comprise of multiple phases where lipid and water coexist
with some emulsiﬁers [31] so it may be feasible to include
this assay in our study. Brieﬂy, oxidation of linoleic acid
in the emulsion generated radicals which in turn caused
the loss of the yellow colour of β-carotene. The presence
of antioxidants will minimize the extent of β-carotene
bleaching by neutralizing the radicals [32].
The antioxidant capacities of the mushroom extracts as
determined by the β-carotene bleaching method were also as
expressed as IC50 valuesas shown in Table 2.L o wI C 50 values
were noted for quercetin and BHA but a relatively higher
IC50 value for ascorbic acid suggests it is a weak antioxidant
based on the results of this assay despite the fact it is a well-
known,polarantioxidant.Ourresultsareinagreementtothe
previousreportswhich pointedoutthatascorbicaciddidnot
show its antioxidant activity under similar assay [31]. Such
phenomenon was termed as “polar paradox” whereby polar
antioxidants remaining in theaqueousphase of the emulsion
aremoredilutedinlipidphaseandthus,theyarelesseﬀective
[32].
Comparison of β-carotene bleaching activity of mush-
rooms with the positive controls revealed that S. com-
mune(IC50 = 2.21mg/mL)showed comparableactivitywith
quercetin (IC50 = 1.86mg/mL) and even more potent
than BHA (IC50 = 2.7 6 m g / m L ) .A p a r tf r o mt h a t ,t h r e e
mushroom species, namely, G. lucidum, H. erinaceus, and L.
edodes (IC50 = 7.94–8.76mg/mL) were more eﬀective than
ascorbicacid(IC50 = 11.50mg/mL).Theantioxidantactivity
of F. velutipes was the weakest, as evidenced by an IC50 that
is approximately 20-fold higher than that of S. commune and
quercetin.
Apparently, some wild mushrooms demonstrated better
inhibition activity in similar assay. Several Portuguese wild
mushrooms were reported to show good antioxidant activi-
ties as evidenced by IC50 in the range of 0.71 to 7.48mg/mL
except for Hydnum repandum which had a higher IC50 of
28.72mg/mL [33]. In the concentration of 4–20mg/mL,
waterextractofLentinula edodes (52.7–75.9%)showedbetter
antioxidant activities than that of V. volvaceae (31.8–65.2%)
[22].
3.5. Inhibition of Lipid Peroxidation of Buﬀered Egg Yolk.
Lipid peroxidation induced by free radical species results
in break down of membrane integrity, aﬀecting its ﬂuidity
and permeability [1]. The initial step, that is, peroxidation
of polyunsaturated fatty acid components in low-density6 Evidence-Based Complementary and Alternative Medicine
lipoproteins of membrane produces several byproducts
which can damage biomolecules. Transition ions may either
generate hydroxyl radicals to initiate the lipid peroxidation
process or propagate the chain process via decomposition of
lipid hyperoxides [25].
In our study, the lipid peroxidation induced by Fe2+
was estimated by the presence of TBARS. The ability of the
mushroom extracts to inhibit peroxidation of phospholipids
in egg yolk is included in Table 2.A tt h ec o n c e n t r a t i o no f1 0
mg/mL, inhibition of lipid peroxidation by the mushroom
extracts was moderate (30.54–57.18%) whereas quercetin,
BHA, and ascorbic acid showed higher inhibition percentage
(77.92–81.93%). G. lucidum exhibited highest inhibition of
lipid peroxidation of 57.18%, followed by P. ﬂorida and A.
auricular-judae with inhibition percentage of 56.58% and
56.41%, respectively. Both V. volvacea and P. ﬂabellatus have
comparable percentage of lipid peroxidation inhibition of
50.09% and 50.00%, respectively.
The ability of mushroom extracts to inhibit lipid
peroxidation on rat brain homogenate has been
reported by Cheung and Cheung [34]w h oi n d i c a t e d
that the dichloromethane subfraction of V. volvacea
(IC50 = 0.109mg/mL) and L. edodes (IC50 = 0.297mg/mL)
were active in inhibiting lipid peroxidation. Phellinus linteus
was reported to inhibit FeCl2-induced lipid peroxidation in
rat brain homogenate with an IC50of 0.485mg/mL [35].
3.6. Reducing Power Ability. The ability of mushroom
extracts to donate electrons could be evaluated using the
reducing power assay. In the presence of antioxidants,
the Fe3+-ferricyanide complex is reduced to the ferrous
form, Fe2+ and the latter can be monitored by measuring
the formation of Perl’s Prussian blue at 700nm; higher
absorbance indicates greater reducing power [16].
The ability of the mushrooms extracts and controls
to reduce Fe3+ to Fe2+ at diﬀerent concentrations are
shown in Table 3.A tt h ec o n c e n t r a t i o no f0 . 5 0 m g / m l ,t h e
positive controls that is quercetin, BHA, and ascorbic acid
exhibited high-reducing capacity of 2.506, 2.405, and 2.380,
respectively, which were distinctively higher than that of
any mushroom extracts (0.011–0.060). Mushroom extracts
showed variable reducing capacity and overall, the reducing
capacity of mushroom extracts increased with increasing
concentration.Amongst themushrooms, G.lucidumshowed
marked increase in reducing power ability of 0.063 to
0.453 in the tested concentration of 0.01 to 1.00mg/mL. At
1.00mg/mL, the reducing power of G. lucidum was 0.453
and this was in accordance to work by Mau et al. [10]
who reported that the reducing power of mature and baby
Ling chih (G. tsugae Murrill) was 0.48 and 0.44, respec-
tively. Agrocybe sp. and P. ﬂorida demonstrated comparative
increase in reducing power ability of 0.054–0.193 and 0.053–
0.110, respectively. Our results for Agrocybe sp. were actually
comparable to Tsai et al. [36] who reported that reducing
p o w e ro fh o tw a t e re x t r a c t so fAgrocybe cylindracea was 0.22
at 1.00mg/mL.
The oyster mushrooms (Pleurotus spp.) exhibited rela-
tively low reducing power of 0.040–0.081 and 0.043–0.165
at the concentration of 0.50 and 1.00mg/mL, respectively.
Lee et al. [37] in their study reported that Pleurotus
citrinopileatus showed better reducing power ability than all
Pleurotus spp. tested in this study. Similarly, Kim et al. [38]
foundthat Pleurotuscornucopiaehasbetterreducingcapacity
than Pleurotus ostreatus and Pleurotus salmoneostramineus.
The reducing power ability of mushrooms can be attributed
to the presence of reductones which reacts with peroxides
and certain precursors to halt peroxides formation as well
as hydrogen-donating ability of these extracts leading to
termination of radical chain reactions.
3.7.CUPRAC Assay. TheCUPRACassay utilisedcopper(II)-
neocuproine (CU(II)-Nc) reagent as the chromogenic oxi-
dizing agent. It is based on the measurement of absorbance
at 450nm by the formation of stable complex between
neocuproine and copper (I) [16]. CUPRAC of the mush-
room extracts was assessed and compared to that of the
positive controls. As shown in Table 4,C U P R A Co ft h e
mushroom extracts was dependent on the concentration
of extract. As expected, the positive controls showed more
pronounced CUPRAC than the mushroom extracts. At the
c o n c e n t r a t i o no f0 . 5 0m g / m L ,C U P R A Co fq u e r c e t i n ,B H A
and ascorbic acid were 2.110, 1.958, and 1.791, respectively.
At similar concentrations, G. lucidum exhibited signiﬁcantly
higher CUPRAC of 1.058 than other mushroom species.
To the best of our knowledge, this is the ﬁrst report on
evaluation of antioxidant activity of hot water extracts
of mushroom fruiting bodies by the CUPRAC method.
Recently, Omar et al. [39] showed the CUPRAC of Lentinus
squarrosulus mycelial extract (0.50mg/mL) was 0.20 ± 0.03
which was lower than CUPRAC of hot water extract of some
of the mushrooms studied (Table 4).
3.8. Antioxidant Index (AI). Mushroom hot water extracts
consist of a mixture of mainly polar compounds; this
complicates the detailed investigation of their antioxidant
activities. Some mushroom species showed diﬀerent levels
of antioxidant activities in diﬀerent assays. For example,
Agrocybe sp. was shown to be a good antioxidant by the
DPPH free radical scavenging assay, reducing power and
CUPRAC but moderate and even weak antioxidant by the
β-carotene bleaching assay and inhibition of lipid peroxida-
tion, respectively. Owing to such chemical complexity and
diﬃculty in comparing results from each assay individually,
Antioxidant Index (AI) introduced by Puttaraju et al. [17]
was constructed to combine the average results of all ﬁve
assays. This would be a more accurate approach to display
the overall antioxidant potential of the mushrooms in terms
of average relative percentages, and comparison can be
made with quercetin which consistently showed excellent
antioxidant activities in all assays. AI aid in ranking the
culinary-medicinal mushrooms according to their antioxi-
dant capacities and this information, if coupled with results
from other biological activities of interest (e.g., inhibition of
ACE), can be useful for health promotion purposes.
As shown in Table 5, G. lucidum exhibited highest
relative antioxidant potential (30.1%) followed closely by
S. commune (27.6%). Several mushrooms showed high to
moderateantioxidant potentialsuch as H.erinaceus (17.7%),Evidence-Based Complementary and Alternative Medicine 7
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V. volvaceae (17.4%), A. auricular-judae (16.9%), and T.
heimii (16.4%).Othermushroomspecies displayedrelatively
low antioxidant potential. Consistent with poor antioxidant
activities noted in most of the assays, F. velutipes was
ranked lowest (12.0%). AI of oyster mushrooms studied
was comparable and decreased in the following order: P.
ﬂabellatus (18.4%) > P. ﬂorida (16.6%) > P. eryngii (15.6%)
> P.cystidiosus,andP. sajor-caju (14.6%).Ontheotherhand,
Puttarajuet al.[17]noted theexistence ofvarietal diﬀerences
inantioxidantactivitiesamongTermitomyces spp.inwhichT.
heimii and T. mummiform showed good antioxidant activity
whereas poor activity was observed in T. microcarpus.S u c h
observationmightbe attributedtothechemicalcomposition
of active compounds in each species.
3.9. ACE Inhibitory Activity. The in vitro ACE inhibitory
activity of mushroom extracts reﬂects potential in vivo anti-
hypertensive eﬀect as previous studies have demonstrated
that inhibition of ACE resulted in decreased blood pressure
in animal models [40–43]. In the ACE inhibitory assay, HHL
acts as the substrate for ACE which catalyses its conversion
to hippuric acid and the dipeptide, histidyl-leucine. ACE
activity is assumed to be directly related to the extent of
hippuric acid release and hence, lower amount of hippuric
acid indicates higher inhibitory activity of extracts towards
ACE.
The ACEinhibitory activity of culinary-medicinal mush-
rooms studied was expressed in terms of IC50 as shown
in Table 6. Our work demonstrated that hot water extract
of G. lucidum exhibited the best ACE inhibitory activity
with IC50 of 0.050mg/mL. This is followed by the oyster
mushrooms, Pleurotus spp., which showed comparatively
lower IC50 values compared to other species with their
IC50 values (inmg/mL) descend in the following order:
P. eryngii (0.067) > P. ﬂabellatus (0.058) > P. sajor-caju
(0.056) > P. cystidiosus (0.054) > P. ﬂorida (0.050). The
close proximity of their IC50 values could be attributed
to structural or chemical similarity of the ACE inhibitors
produced by the species from the same genus. Accordingly,
the ACE inhibitory activities of hot water extract of G.
lucidum and Pleurotus spp. were better than water extract
of Tricholoma giganteum (IC50 = 0.31mg/mL) [40], Grifola
frondosa (IC50 = 0.28–0.31mg/mL) [5], and several strains
of Pholiota adiposa (IC50 = 0.21–0.95mg/mL) [41]. Other
mushroom species investigated in this study were shown to
be relatively weak in inhibiting ACE with IC50 in the range of
0.320 to 0.890mg/mL.
Evaluation of ACE inhibitory activity of these mush-
rooms was carried out using only hot water extracts as
water extract (hot and cold) of mushrooms were reported
to exhibit higher activity than methanol or ethanol extracts
[5, 40]. Eﬀectiveness of both hot and cold water extracts
is still not conclusive based on their ﬁndings. Apparently,
it varies according to mushroom species and inﬂuenced by
factors like temperature and extraction time [5]. It appears
that ACE inhibitory activity increased when extraction time
was prolonged. In cases where hot water extract showed
lower ACE inhibition, denaturation, or inactivation of the
bioactive compounds due to exposure to high temperature
has been suggested as the most likely reason. Working on
the wild medicinal mushroom Taiwanofungus camphorates,
Liu et al. [42] reported that only methanol extract exhibited
ACE inhibitory activity; the hot water extract showed no
activity atall. Nevertheless, isolation and puriﬁcation ofACE
inhibitorsfromhotwaterextractsofseveralmushroomshave
beenreported.Hagiwaraetal.[43]identiﬁedasugar-alcohol,
D-mannitol (IC50 = 3.00mg/mL) as the active compound of
Pleurotus cornucopiae. L-pipecolic acid (IC50 = 23.7mg/mL)
puriﬁed from the hot water extract of Sarcodon aspratus
moderatelyinhibitedACEactivityasreported byKiyotoetal.
[44].
It is interesting to point out that G. lucidum which
possess the highest phenolic content also exhibited highest
ACE inhibitory activity in our study. Various medicinal
properties ofG. lucidummight be attributed to its signiﬁcant
antioxidant activities as suggested by Lakshimi et al. [45].
The antihypertensive eﬀect of G. lucidum, especially in the
ﬁeld of traditional Chinese medicine is well known. In fact,
the in vitro ACE inhibitory eﬀect of G. lucidum has been
reported earlier. Starting from the 70% methanol extract,
Morigiwa et al. [46] successfully isolated and characterized
ﬁve new triterpenes in addition to other ﬁve known triter-
penes. All showed ACE inhibitory activity with ganoderic
acid F exhibited the highest ACE inhibitory eﬀect.
In our study, the hot water extract of G. lucidum and
P. ﬂorida gave the lowest IC50 value amongst mushrooms
studied. Based on these observations, it is possible to suggest
that the hot water extract of both mushroom species could
possibly contain eﬀective ACE inhibitor or present in high
amount as evidenced by high ACE inhibitory activity at
low concentration of extracts. The active compound in the
extracts could be proteins and we are currently working
on the isolation, characterization, and puriﬁcation of these
potential ACE inhibitor proteins. Previously, peptides with
ACE inhibitory activity were isolated from water extracts of
edible mushrooms with the following amino acid sequences:
Val-Ile-Glu-Lys-Tyr-Pro from G. frondosa [6] and Gly-Glu-
Pro from T. giganteum [40].
3.10. Antioxidant Capacities of Mushroom Extracts in Relation
to Total Phenolics and Other Compounds. Total phenolic
content of the mushroom extracts can be related to their
antioxidant capacities. Our ﬁndings showed that there was
a good correlation (R2 = 0.8181) between total phenolics
and DPPH free radical scavenging activity of the mushroom
extracts. This was in accordance to the ﬁndings by several
authors who reported that total phenolic content correlated
with the free radical scavenging activity of other mushrooms
[17, 20]. Total phenolics also showed strong correlation with
antioxidant capacitydetermined bythereducingpower assay
(R2 = 0.8546) and CUPRAC (R2 = 0.8279), suggesting that
the reductive potential of the mushroom extracts is mainly
due to phenolic compounds. In fact, antioxidant activity was
shown to be concomitant with the reducing capacity, indi-
cating that antioxidant capacity of the mushroom extracts
might be due to its reducing capacity [11]. High free radical
scavenging activity, reducing power ability and CUPRAC of
somemushrooms, forexample,G.lucidummaybeattributed10 Evidence-Based Complementary and Alternative Medicine
Table 5: Grading of selected culinary-medicinal mushrooms for total antioxidant activity according to the method by Puttaraju et al. [17].
Relative percentage of each antioxidant capacity assay
Mushroom species/positive controls DPPH β-CB ILP RPA CUPRAC Average of total antioxidant activity
(Relative percentage = antioxidant index)
(1) Quercetin 100.0 100.0 100.0 100.0 100.0 100.0
(2) BHA 30.5 67.4 86.0 96.0 92.8 74.5
(3) Ascorbic acid 41.6 16.2 93.0 95.0 84.9 66.2
(4) Ganoderma lucidum 0.6 23.4 65.5 10.8 50.1 30.1
(5) Schizophyllum commune 0.1 84.1 41.5 0.9 11.6 27.6
(6) Pleurotus ﬂabellatus 0.2 15.5 57.3 3.2 15.5 18.4
(7) Hericium erinaceus 0.1 21.2 54.4 0.9 12.0 17.7
(8) Volvariella volvaceae 0.2 10.4 57.2 4.7 14.4 17.4
(9) Auricularia auricular-judae 0.1 6.7 64.6 2.4 10.8 16.9
(10) Pleurotus ﬂorida 0.2 7.4 64.8 2.8 7.8 16.6
(11) Termitomyces heimii 0.1 14.6 53.0 5.5 8.7 16.4
(12) Lentinula edodes 0.2 22.4 43.8 1.4 11.8 15.9
(13) Pleurotus eryngii 0.2 7.5 54.8 2.3 13.0 15.6
(14) Agrocybe sp. 0.3 14.4 38.2 3.4 18.8 15.0
(15) Pleurotus sajor-caju 0.1 10.6 49.2 3.2 9.9 14.6
(16) Pleurotus cystidiosus 0.1 7.1 57.0 1.6 7.1 14.6
(17) Flammulina velutipes 0.1 4.8 47.7 0.7 6.5 12.0
The average of DPPH (free radical scavenging activity), β-CB (β-carotene bleaching assay), ILP (inhibition of lipid peroxidation), RPA (reducing power
ability),and CUPRAC (cupricion reducing antioxidant capacity)of quercetin is based on 100. Antioxidant potential (average of total antioxidant activity) of
other positive controls and mushrooms studied was expressed as average relative percentages compared to quercetin.
Table 6: ACE inhibitory activity of selected culinary-medicinal
mushrooms.
Mushroom species ACE inhibitory activity
IC50 (mg/mL)
Agrocybe sp. 0.890 ±0.046
Auricularia auricular-judae 0.510 ±0.018
Ganoderma lucidum 0.050 ±0.009
Hericium erinaceus 0.580 ±0.023
Pleurotus cystidiosus 0.054 ±0.002
Pleurotus eryngii 0.067 ±0.026
Pleurotus ﬂabellatus 0.058 ±0.002
Pleurotus ﬂorida 0.050 ±0.013
Pleurotus sajor-caju 0.056 ±0.012
Schizophyllum commune 0.320 ±0.070
Volvariella volvaceae 0.760 ±0.023
IC50 valueswere interpolated fromdose-response curve for ACEinhibition
of each mushroom species. Values were expressed as mean ± standard
deviation of three replicate determinations.
to high phenolic content as evidenced by ﬁndings from
this study. According to Dorman et al. [24], the ability
of any extracts to reduce Fe3+ (a pro-oxidant metal ion)
suggests that they may act as free radical chain terminators
and transform reactive free radical species into more stable
nonradical products. This is in accordance with Puttaraju
et al. [17] who reported the strong correlation (R2 ∼
0.95) between the phenolics and reducing power ability
of several indigenous mushrooms in India. They further
suggested that the variation in total antioxidant activity
might be attributed to the combinational eﬀect of diﬀerent
phenolic compounds. Based on the close relationship of
total phenolics and antioxidant capacities determined by
the three assays mentioned above, it might be feasible to
suggest phenolics as the major antioxidant components in
the mushroom extracts, contribute directly to antioxidative
action via radical scavenging ability.
However, the weak correlation between total phenolics
and antioxidant capacities as determined by the inhibition
of lipid peroxidation and β-carotene bleaching assays could
imply that phenolics do not act as antioxidants under these
conditions. The possibility of active constituents, which
are nonphenolic in nature, present in some mushroom
extracts must be taken into consideration, for example, total
phenolics in S. commune was low but the extracts showed
great inhibitory action towards β-carotene bleaching (IC50 =
2.21mg/mL). Similarly, A. auricular-judae and P. ﬂorida was
among the mushrooms with remarkable inhibitory eﬀect on
lipid peroxidation, yet total phenolics in both mushrooms
were very low. Perhaps, the antioxidant capacities observed
could be attributed to other compounds with reducing
capabilities, for example, polysaccharides which can be
extracted into the hot water extracts. Antioxidative eﬀect of
polysaccharides from mushrooms has been reported recently
[47].
Chemical constituents in hot water extracts of several
mushrooms have been reported earlier, providing insights
into the spectrum of potential antioxidant compoundsEvidence-Based Complementary and Alternative Medicine 11
[10, 11, 29, 36, 37]. Ascorbic acid, tocopherols, and β-
carotene have been reported to be some of the naturally
occurring antioxidant compounds in mushrooms [21]. It
has been suggested that these compounds may not be
extracted into the hot water extracts due to the heat-labile
characteristic of ascorbic acid as well as fat-soluble nature
of tocopherols and β-carotene [37]. Nevertheless, there were
reports on detection of ascorbic acid and tocopherolsin very
low amount from hot water extracts of several mushrooms
[10, 11, 29, 36, 48]. Identiﬁcation of bioactive compounds
conferring antioxidant activities would be useful as pure
compounds might exhibit higher activity. However, the
possibility of various compounds working in a synergistic
manner cannot be excluded and in this case, the entire
water-soluble fractions (decoctions) are more precious than
isolated constituents [49].
Our results also indicated that there was no correlation
between ACE inhibitory activity and total phenolics. Based
on the literature, ACE inhibitors isolated from mushrooms
are mainly peptides [5, 40]. In these cases, these bioactive
peptides might block the active site of ACE via substrate-
enzyme binding, inhibiting the conversion of angiotensin I
to angiotensin II, a potent vasopressor. Apart from inhi-
bition of ACE, blood-pressure-lowering property of these
mushroom extracts might be due to other mechanisms such
as modulation of nitric oxide production, enhancement
of endothelial function, and scavenging of free radicals
[7]. Further work is needed to identify potential bioactive
compounds responsible for the observed antioxidant and
ACE inhibitory activities.
4.Conclusions
Culinary-medicinal mushrooms studied showed good
antioxidant capacity and potential antihypertensive eﬀect
as demonstrated by their inhibitory eﬀect towards ACE.
Antioxidants work better in teams, having a broader
spectrum oﬀers more complete protection considering the
fact that each antioxidant compound works diﬀerently
and joint eﬀort creates synergy. Therefore, mushrooms in
human diets might serve as possible protective agents to help
us reduce oxidative damage and the risk of cardiovascular
diseases. However,in vitro ﬁndingsareofuncertainrelevance
to the in vivo situation in healthy humans. More work is
required to investigate the eﬀects by monitoring a battery of
markers in vivo oxidative damage or oxidative stress.
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